Genomic DNA hypomethylation as a biomarker for bladder cancer susceptibility in the Spanish Bladder Cancer Study: a case

Genomic DNA hypomethylation as a biomarker for bladder cancer susceptibility in the Spanish Bladder Cancer Study: a case–control study

Published:2008-04 Issue:4 Volume:9 Page:359-366
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Moore Lee E,Pfeiffer Ruth M,Poscablo Cristina,Real Francisco X,Kogevinas Manolis,Silverman Debra,García-Closas Reina,Chanock Stephen,Tardón Adonina,Serra Consol,Carrato Alfredo,Dosemeci Mustafa,García-Closas Montserrat,Esteller Manel,Fraga Mario,Rothman Nathaniel,Malats Núria

Publisher

Elsevier BV

Subject

Oncology

Reference39 articles.

1. Aging, DNA methylation and cancer;Issa;Crit Rev Oncol Hematol,1999

2. Cancers as an epigenetic disease: DNA methylation and chromatin alterations in human tumours;Esteller;J Pathol,2002

3. DNA hypomethylation on pericentromeric satellite regions significantly correlates with loss of heterozygosity on chromosome 9 in urothelial carcinomas;Nakagawa;J Urol,2005

4. Centrosomal abnormality is common in and a potential biomarker for bladder cancer;Jiang;Int J Cancer,2003

5. Centrosome hyperamplification and chromosomal instability in bladder cancer;Kawamura;Eur Urol,2003

Cited by 197 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the Utility of Long Non-Coding RNAs for Assessing the Health Consequences of Vaping;International Journal of Molecular Sciences;2024-08-05

2. Metabolic biomarkers in irritable bowel syndrome diagnosis;Clinica Chimica Acta;2024-06

3. Integrated bioinformatics investigation of adenylyl cyclase family co-expression network in bladder cancer followed by preliminary validation of member 2 (ADCY2) in tumorigenesis and prognosis;Translational Cancer Research;2024-05

4. Blood leukocytes as a non-invasive diagnostic tool for thyroid nodules: a prospective cohort study;BMC Medicine;2024-04-02

5. Resilience to oral cancer development in individuals with debilitating habits: Unravelling the enigma;Oral Oncology Reports;2023-12